APP and Alzheimer disease: Similarly, a decline in CBF has been repeatedly documented prior to the development of cognitive defects or amyloid plaques in multiple transgenic mouse AD models (APP23, J20, APP/PS1, 5xFAD, and Tg2576) that overexpress APP [12,13,16,76,143].